Exp Mol Med.  2012 Jan;44(1):26-35. 10.3858/emm.2012.44.1.002.

Differentiation of human labia minora dermis-derived fibroblasts into insulin-producing cells

Affiliations
  • 1Laboratory of Cell Function Regulation, College of Life Sciences and Biotechnology, Korea University, Seoul 136-713, Korea. bioseung@korea.ac.kr
  • 2Division of Biotechnology, College of Life Sciences and Biotechnology, Korea University, Seoul 136-713, Korea.
  • 3Division of Stem Cell Research Institute, Stemmedience Corp., Seoul 135-090, Korea.
  • 4SamKwang Medical Laboratories, Seoul 137-130, Korea.
  • 5Department of Pathology, College of Medicine, Korea University Guro Hospital, Seoul 152-703, Korea.

Abstract

Recent evidence has suggested that human skin fibroblasts may represent a novel source of therapeutic stem cells. In this study, we report a 3-stage method to induce the differentiation of skin fibroblasts into insulin-producing cells (IPCs). In stage 1, we establish the isolation, expansion and characterization of mesenchymal stem cells from human labia minora dermis-derived fibroblasts (hLMDFs) (stage 1: MSC expansion). hLMDFs express the typical mesenchymal stem cell marker proteins and can differentiate into adipocytes, osteoblasts, chondrocytes or muscle cells. In stage 2, DMEM/F12 serum-free medium with ITS mix (insulin, transferrin, and selenite) is used to induce differentiation of hLMDFs into endoderm-like cells, as determined by the expression of the endoderm markers Sox17, Foxa2, and PDX1 (stage 2: mesenchymal-endoderm transition). In stage 3, cells in the mesenchymal-endoderm transition stage are treated with nicotinamide in order to further differentiate into self-assembled, 3-dimensional islet cell-like clusters that express multiple genes related to pancreatic beta-cell development and function (stage 3: IPC). We also found that the transplantation of IPCs can normalize blood glucose levels and rescue glucose homeostasis in streptozotocin-induced diabetic mice. These results indicate that hLMDFs have the capacity to differentiate into functionally competent IPCs and represent a potential cell-based treatment for diabetes mellitus.

Keyword

cell differentiation; dermis; endoderm; fibroblasts; humans; insulin; mesenchymal stem cells

MeSH Terms

Animals
Biological Markers/metabolism
*Cell Culture Techniques
*Cell Differentiation
Cell Proliferation/drug effects
Cell Separation
Cells, Cultured
Dermis/*cytology/drug effects
Diabetes Mellitus, Experimental/*surgery
Female
Fibroblasts/*cytology/drug effects
Genitalia, Female/*cytology
Glucose/metabolism
Hepatocyte Nuclear Factor 3-beta/metabolism
Homeodomain Proteins/metabolism
Humans
Insulin/pharmacology/secretion
Insulin-Secreting Cells/*cytology/metabolism
*Islets of Langerhans Transplantation
Mesenchymal Stem Cells/*cytology/drug effects/metabolism
Mice
Mice, Nude
Niacinamide/pharmacology
Recovery of Function
SOXF Transcription Factors/metabolism
Sodium Selenite/pharmacology
Trans-Activators/metabolism
Transferrin/pharmacology
Full Text Links
  • EMM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr